Sign in to view content

Intermittent to Continuous Therapy for Diabetic Macular Edema leads to Reduction in Treatment Frequency and Reduced Retinal Thickness Fluctuations

Seenu M. Hariprasad, MD

Video
Published 2019

Related

New Data and Insights from Several DRCR.net Protocols
Lee Jampol, MD
Updates from the Field
2017
Percentage of Patients Maintained on Quarterly Anti-VEGF Dosing for the Treatment of Neovascular Age-Related Macular Degeneration
David A. Eichenbaum, MD, FASRS
Updates from the Field
2018
Biosimilar Paradox: How Biosimilar Use Will Increase Patient and Healthcare Costs
Ravi Parikh, MD MPH
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more